Not Applicable

Nippon India Nifty Pharma ETF

An open ended scheme replicating/ tracking NIFTY Pharma Index

Official details checked 06 September 2026 · latest available AMFI NAV dated 04 Sep 2026
Reference NAV₹27.2300Nippon India Nifty Pharma ETF - Direct Plan · NAV date 04 Sep 2026
RiskometerVery HighCan change monthly
Expense ratioRegular 0.00%, Direct 0.24%Official stated figure; verify current TER
Allotment / launch02-Jul-2021Nippon India Mutual Fund
Full official AMFI Scheme Summary Document available below.

Saved AMFI NAV is visible. Checking for the latest available AMFI report after page load · saved snapshot 04 Sep 2026.

Plain-language summary

Primarily market-linked growth exposure

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

Who may study it further

Investors with a long horizon who can tolerate meaningful falls in value.

Main risks to understand

Share-price volatility, valuation risk, concentration and tracking risk where applicable.

Not an income promise: The objective describes what the manager aims to do. It is not a guaranteed result, return or capital-protection statement.
Portfolio design

How the money may be invested

Securities constituting securities constituting Nifty Pharma Index - 95% to 100%, Money Market Instruments including TriParty Repo on governement securities or T-Bills, cash & cash equivalents or Liquid Schemes - 0% to 5%.

SEBI category
Not Applicable
Fund type
An open ended scheme replicating/ tracking NIFTY Pharma Index
Primary benchmark
Nifty Pharma TRI
Top holdings

Use the latest monthly portfolio

Top holdings are the largest securities currently owned by the scheme. Names and weights can change every month, so a copied list can become misleading. Open the AMC's current official portfolio or factsheet below and look for this exact fund name.

Live verificationNippon India Nifty Pharma ETFConfirm the reporting month, security name, sector and percentage of net assets.
Fund management

Manager and scheme tenure

Fund manager(s)
Jitendra Tolani
Manager tenure on this scheme
Since 01-Feb-2025
Role / co-management
Primary

The tenure above is experience managing this scheme, not the manager's total career experience. For education, qualifications and prior roles, open the latest official AMC factsheet or manager profile below.

Plans and options

Latest NAV records

NAV is a per-unit accounting value. Compare returns, portfolio, risk and cost — never choose a fund only because its NAV looks low.

Plan / option reported by AMFINAVDate
Nippon India Nifty Pharma ETF - Direct Plan₹27.230004 Sep 2026
Costs and access

What you pay and how money moves

Stated expense ratio
Regular 0.00%, Direct 0.24%
Exit load
Not Applicable
Minimum application
In creation unit size of 75,000 units and in multiples thereafter However, in case of large investors, the execution value must be greater than Rs. 25 crores · multiples of Not Applicable
SIP frequency
Refer to the current official scheme document.
Minimum SIP amount
Refer to the current official scheme document.
Minimum instalments
Refer to the current official scheme document.
Expense ratios change. Direct and regular plans normally have different expense ratios. Read the latest TER disclosure before investing.
Premium-free process

How a mutual-fund investment is paid

  1. Complete KYCIdentity, PAN, bank and contact verification are required.
  2. Choose route and optionUnderstand direct vs regular and growth vs IDCW before selecting.
  3. Choose SIP or lump sumSIP uses an automated mandate; lump sum is a one-time payment.
  4. Receive units at applicable NAVCut-off time, cleared funds and scheme rules determine the applicable NAV.
  5. Review, do not chaseTrack goal fit, risk, manager/mandate changes, costs and portfolio — not daily noise.
Original documents

Download and verify at source

The packaged Scheme Summary PDF is the official AMFI file, unchanged. Live AMC links are included for time-sensitive factsheets, top holdings and portfolios.

Source verification date: 06 September 2026. If a live document differs from this page, rely on the newer official document.

Need a human explanation?

Talk through the fund, costs and risks before deciding.

Educational support only — no promise of returns.

Call expert+91 9426587283 Chat with expertWhatsApp